The number of infections with a type of serious fungal infections among Covid-19 patients in India has increased, known as mucormycosis, which is caused by mold that grows in humid environments and attacks the respiratory system, and it was present in the country before the spread of the epidemic.
The case of mold fungus is relatively rare, but the death rate for those infected is high, and it alarmed the authorities, which took measures to prevent the spread of the infection.
And local media in the western state of Maharashtra, where the commercial center of Mumbai is located, which has been severely affected by the epidemic, reported that about 200 patients who had recovered from Covid-19 were being treated from this disease and that eight of them had died, according to the “Al Hurra” channel.
And in the western state of Gujarat, the government has ordered separate hospital wards to treat people with this bacterial infection, and has ordered that a drug be made available to treat it.
The Indian Council of Medical Research (ICMR) said, Monday, that among the factors that lead to the emergence of this infection are uncontrolled diabetes, use of steroids, prolonged stay in the intensive care unit, malignancies and others.
He stated that neglecting this case leads to problems “in the sinuses or lungs of individuals after inhaling fungal spores from the air.”
Symptoms include pain, redness around the eyes and nose, fever, headache, cough, shortness of breath, vomiting blood, and mental state change.
Although the condition is rare, doctors and medical experts say that it affects some Covid-19 patients due to their weak immunity and other health problems, especially diabetes.
Some experts attribute infection with these fungi to treating Covid-19 patients with oxygen at home without adhering to proper hygiene rules, and some resort to home treatment due to overcrowding in hospitals.